Short interest for Tenet Healthcare gives investors a sense of the degree to which investors are betting on the decline of Tenet Healthcare's stock. Short interest data is updated every two weeks.

Tenet Healthcare Stock (NYSE:THC), Short Interest Report

Tenet Healthcare

Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Image45

News

Intraday Update

Markets

Movers

ADXN

AGBA

AKLI

ARCB

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLND

CECO

CETX

CHGG

COUR

CSLR

CYCC

DARE

EGOX

ELYM

ETWO

FFIV

GEHC

HEES

HLIT

LICN

MIND

MRIN

MSTR

MULN

NIVF

NRXP

RMBS

SGBX

SWVL

TREE

UAVS

VNCE

YUMC

Why H&amp;E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Eli Lilly

ACIW

AMKR

CVLT

NXPI

ZBRA

Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday

Earnings

Large Cap

Guidance

Health Care

General

Discover Tenet Healthcare&#39;s robust first-quarter performance, boasting $5.37 billion in sales, a 7% Y/Y increase. With strong revenue growth, admissions, and profitability, Tenet is raising its fiscal year 2024 revenue guidance to $20-$20.4 billion.

Why Is Hospital Chain Operator Tenet Healthcare Stock Soaring On Tuesday?

Tenet Healthcare Corporation Common Stock

Tenet Healthcare Corp

THC BIOMED INTL LTD ORD by THC BioMed Intl Ltd.

THC Biomed International Ltd

TH International Limited - Ordinary shares

TH International Ltd

Thunder Bridge Capital Partners IV, Inc. - Class A Common Stock

Thunder Bridge Capital Partners IV Inc

Thunder Bridge Capital Partners IV, Inc. - Unit

Thunder Bridge Capital Partners IV, Inc. - Warrant

THC THERAPEUTICS INC by THC Therapeutics, Inc.

THC Therapeutics Inc

Spinnaker ETF Series Cannabis ETF

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Outperform and raises the price target from $109 to $136.

Price Target

Analyst Ratings

RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $136

WIIM

Tenet Healthcare shares are trading higher after multiple firms raised their respective price targets on the stock.

UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Buy and raises the price target from $137 to $150.

UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $150

Tenet Healthcare's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) short percent of float has fallen 4.12% since its last report. The company recently reported that it has 4.26 million shares sold short, which is 5.59% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Tenet Healthcare Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714579224_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Tenet Healthcare has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Tenet Healthcare's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Tenet Healthcare's peer group average for short interest as a percentage of float is 9.06%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Tenet Healthcare's Recent Short Interest

Mizuho analyst Ann Hynes reiterates Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Buy and raises the price target from $118 to $130.

Reiteration

Mizuho Reiterates Buy on Tenet Healthcare, Raises Price Target to $130

Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Buy and raises the price target from $120 to $130.

Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $130

Stephens &amp; Co. analyst Scott Fidel maintains Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) with a Equal-Weight and raises the price target from $95 to $122.

Stephens & Co. Maintains Equal-Weight on Tenet Healthcare, Raises Price Target to $122

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$800.00</td>
<td>$35.4K</td>
<td>1.4K</td>
<td>1.4K</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$95.00</td>
<td>$27.5K</td>
<td>2.9K</td>
<td>1.0K</td>
</tr>
<tr>
<td>SNDL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$2.50</td>
<td>$31.3K</td>
<td>7.6K</td>
<td>942</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/10/24</td>
<td>$25.00</td>
<td>$34.7K</td>
<td>44.8K</td>
<td>912</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$430.00</td>
<td>$66.9K</td>
<td>58</td>
<td>181</td>
</tr>
<tr>
<td>ZTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$160.00</td>
<td>$27.6K</td>
<td>807</td>
<td>66</td>
</tr>
<tr>
<td>SYK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/17/24</td>
<td>$340.00</td>
<td>$96.2K</td>
<td>732</td>
<td>64</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$850.00</td>
<td>$37.4K</td>
<td>2.1K</td>
<td>56</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$450.00</td>
<td>$36.9K</td>
<td>876</td>
<td>12</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$65.00</td>
<td>$43.6K</td>
<td>38</td>
<td>10</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For LLY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), we notice a call option trade that happens to be bearish, expiring in 17 day(s) on May 17, 2024. This event was a transfer of 30 contract(s) at a $800.00 strike. The total cost received by the writing party (or parties) was $35.4K, with a price of $1180.0 per contract. There were 1434 open contracts at this strike prior to today, and today 1446 contract(s) were bought and sold. 
• Regarding THC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>), we observe a call option trade with bearish sentiment. It expires in 17 day(s) on May 17, 2024. Parties traded 17 contract(s) at a $95.00 strike. The total cost received by the writing party (or parties) was $27.5K, with a price of $1620.0 per contract. There were 2959 open contracts at this strike prior to today, and today 1052 contract(s) were bought and sold. 
• Regarding SNDL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>), we observe a call option sweep with bullish sentiment. It expires in 80 day(s) on July 19, 2024. Parties traded 897 contract(s) at a $2.50 strike. This particular call needed to be split into 23 different trades to become filled. The total cost received by the writing party (or parties) was $31.3K, with a price of $35.0 per contract. There were 7602 open contracts at this strike prior to today, and today 942 contract(s) were bought and sold. 
• Regarding PFE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), we observe a put option sweep with bearish sentiment. It expires in 10 day(s) on May 10, 2024. Parties traded 707 contract(s) at a $25.00 strike. This particular put needed to be split into 28 different trades to become filled. The total cost received by the writing party (or parties) was $34.7K, with a price of $49.0 per contract. There were 44816 open contracts at this strike prior to today, and today 912 contract(s) were bought and sold. 
• Regarding ISRG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), we observe a call option sweep with bullish sentiment. It expires in 80 day(s) on July 19, 2024. Parties traded 181 contract(s) at a $430.00 strike. This particular call needed to be split into 33 different trades to become filled. The total cost received by the writing party (or parties) was $66.9K, with a price of $370.0 per contract. There were 58 open contracts at this strike prior to today, and today 181 contract(s) were bought and sold. 
• For ZTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTS#NYSE">ZTS</a>), we notice a put option sweep that happens to be bullish, expiring in 17 day(s) on May 17, 2024. This event was a transfer of 50 contract(s) at a $160.00 strike. This particular put needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $27.6K, with a price of $550.0 per contract. There were 807 open contracts at this strike prior to today, and today 66 contract(s) were bought and sold. 
• Regarding SYK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>), we observe a call option sweep with neutral sentiment. It expires in 17 day(s) on May 17, 2024. Parties traded 125 contract(s) at a $340.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $96.2K, with a price of $770.0 per contract. There were 732 open contracts at this strike prior to today, and today 64 contract(s) were bought and sold. 
• For REGN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>), we notice a put option sweep that happens to be bullish, expiring in 17 day(s) on May 17, 2024. This event was a transfer of 44 contract(s) at a $850.00 strike. This particular put needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $37.4K, with a price of $850.0 per contract. There were 2130 open contracts at this strike prior to today, and today 56 contract(s) were bought and sold. 
• For UNH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), we notice a call option trade that happens to be bullish, expiring in 17 day(s) on May 17, 2024. This event was a transfer of 10 contract(s) at a $450.00 strike. The total cost received by the writing party (or parties) was $36.9K, with a price of $3695.0 per contract. There were 876 open contracts at this strike prior to today, and today 12 contract(s) were bought and sold. 
• For VKTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>), we notice a call option trade that happens to be bullish, expiring in 199 day(s) on November 15, 2024. This event was a transfer of 17 contract(s) at a $65.00 strike. The total cost received by the writing party (or parties) was $43.6K, with a price of $2570.0 per contract. There were 38 open contracts at this strike prior to today, and today 10 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

ISRG

REGN

SNDL

VKTX

10 Health Care Stocks With Whale Alerts In Today's Session

Shares of H&amp;E Equipment Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEES#NASDAQ">HEES</a>) fell sharply during Tuesday's session following <a href="https://www.benzinga.com/quote/HES/earnings">mixed first-quarter results</a>.
H&amp;E Equipment posted GAAP earnings of 71 cents per share, versus market estimates of 77 cents per share. The company's quarterly sales came in at $371.357 million versus expectations of $352.518 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
H&amp;E Equipment Services shares dipped 18.2% to $48.45 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Akili, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKLI#NASDAQ">AKLI</a>) shares jumped 67.2% to $0.3927 after the company announced Shionogi has canceled and forgiven a $5.0 million long-term debt obligation and agreed to make certain payments for SDT-001.</li>
<li>AGBA Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NASDAQ">AGBA</a>) gained 57.5% to $3.70 after the company highlighted plans for its previously-announced merger with Triller.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) climbed 55.4% to $2.12 after falling over 9% on Monday.</li>
<li>Global Mofy Metaverse Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares gained 50.2% to $1.40 after the company&#8217;s Gauss AI teamed with Heartdub to develop the Gausspeed generative AI platform.</li>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) rose 40.8% to $15.49 after the company reported better-than-expected first-quarter financial results and raised its FY2024 sales guidance.</li>
<li>Eliem Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELYM#NASDAQ">ELYM</a>) gained 39.4% to $7.00.</li>
<li>Swvl Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWVL#NASDAQ">SWVL</a>) surged 29.8% to $13.14 after announcing results for the fiscal year 2023.</li>
<li>Next.e.GO N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGOX#NASDAQ">EGOX</a>) gained 26.4% to $0.0349.</li>
<li>Blend Labs, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) shares climbed 25.8% to $2.83 after the company announced a strategic partnership with Haveli Investments, including a $150 million investment.</li>
<li>Daré Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DARE#NASDAQ">DARE</a>) rose 24.2% to $0.3460 after the XOMA acquired an economic interest in the company&#8217;s women&#8217;s health assets. Also, the company announced that the transaction allows it to focus on advancing Phase 3 first-in-category women&#8217;s health product candidates.</li>
<li>LendingTree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) gained 24.2% to $46.39 after the company beat first-quarter estimates and issued strong guidance.</li>
<li>MIND Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) rose 24% to $5.85 following quarterly results.</li>
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) gained 19.8% to $6.85.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) rose 19.2% to $11.19 following a first-quarter revenue beat.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) rose 18.8% to $3.1002 after the company announced the launch of its AI-powered Anomaly Detector.</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) gained 15.5% to $59.94 following upbeat quarterly results.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) gained 15.2% to $46.88 following better-than-expected earnings.</li>
<li>LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) rose 13.4% to $9.32 following strong quarterly earnings.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) gained 13.3% to $1.53.</li>
<li>E2open Parent Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) rose 12.5% to $4.7950 following upbeat results.</li>
<li>Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) shares climbed 12.1% to $40.04 as the company reported stronger-than-expected results for its first quarter on Monday. The company said Jeff Cote will retire as CEO and President. Sensata said it sees second-quarter adjusted earnings of 89 cents to 95 cents per share on revenue of $1.025 billion to $1.055 billion.</li>
<li>Addex Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) jumped 10.3% to $8.31. Addex shares dipped 53% on Monday after the company announced the Phase 2 ADX71149 epilepsy study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.</li>
<li>AgEagle Aerial Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#NASDAQ">UAVS</a>) gained 10.4% to $0.77. AgEagle announced $3.4 million drone sale to French Army.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) rose 9.2% to $108.28 after the company reported better-than-expected first quarter earnings and issued strong guidance.</li>
<li>Brinker International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) gained 7.5% to $53.38 after the company reported strong third-quarter financial results and raised FY24 guidance.</li>
<li>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) rose 6.6% to $785.51 after the company raised its FY24 revenue guidance.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) gained 5.5% to $97.25 following a first-quarter earnings beat.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Lichen China Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) fell 30.6% to $1.4127 after surging 48% on Monday.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) declined 29.7% to $1.25.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares fell 26.1% to $5.30 after the company posted first-quarter results and named Nathan Shultz as CEO.</li>
<li>NRx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) dipped 25% to $2.6592 after the company announced findings from its Phase 2b/3 trial of NRX-101 vs. Lurasidone.</li>
<li>Bakkt Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) fell 23.5% to $7.62. Bakkt Holdings is expected to release its first quarter 2024 earnings on Tuesday, May 14.</li>
<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) shares declined 22.6% to $27.50 after the company reported mixed first-quarter financial results.</li>
<li>Vince Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) were down 21.4% to $1.6536 after the company posted fourth-quarter results.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) fell 20.1% to $1.63.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) dipped 18% to $1.14.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) declined 16.4% to $1,081.53 after the company reported worse-than-expected financial results for the first quarter.</li>
<li>Safe &amp; Green Holdings Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) fell 16% to $0.1185 after declining 4% on Monday.</li>
<li>ArcBest Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) declined 15.8% to $108.96 after the company reported worse-than-expected first quarter adjusted EPS results.</li>
<li>CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) fell 15% to $21.59 after the company reported worse-than-expected first-quarter sales results.</li>
<li>GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) declined 13.2% to $77.22 following a first-quarter earnings miss.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares declined 13.1% to $10.34 after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Complete Solaria, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) fell 12.5% to $0.6393. Complete Solaria shares jumped 92% on Monday after the company named T.J. Rodgers as CEO.</li>
<li>Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) fell 11% to $5.18 after the company reported worse-than-expected quarterly sales results.</li>
<li>Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) declined 9.3% to $7.39 on reports NBCUniversal is preparing an offer that could take NBA rights from TNT.</li>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) fell 7.6% to $168.36. F5 reported upbeat earnings for its second quarter, but issued weak forecast for the third quarter.</li>
<li>Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) declined 7.5% to $58.80 following quarterly results.</li>
<li>The Macerich Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) fell 7.4% to $14.82 following quarterly earnings.</li>
<li>Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) shares declined 7.3% to $37.13. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares declined 7.3% to $56.10 following first-quarter results.</li>
</ul>
Now Read This: <a href="http://Domino's Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday">Domino&#8217;s Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday</a>

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

U.S. stocks were lower, with the Dow Jones index falling over 100 points on Tuesday.
Shares of Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) rose sharply during Tuesday's session after the company raised its <a href="https://www.benzinga.com/general/biotech/24/04/38521126/eli-lillys-weight-loss-drug-still-going-strong-boosts-annual-forecast">FY24 revenue guidance</a>.
Eli Lilly reported first-quarter revenue of $8.77 billion, up 26% year over year, marginally missing the consensus of $8.92 billion, driven by increases of 16% in volume and 10% due to higher realized prices. Eli Lilly posted an adjusted EPS of $2.58, beating the consensus of $2.46, higher than $1.62 a year ago, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Eli Lilly forecasts fiscal year 2024 sales of $42.4 billion -$43.6 billion versus prior guidance of $40.4 billion-$41.6 billion and consensus of $41.36 billion.
Eli Lilly shares surged 6.6% to $785.51 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) shares jumped 40.8% to $15.49 after the company reported better-than-expected first-quarter financial results and raised its FY2024 sales guidance.</li>
<li>Blend Labs, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) shares surged 25.8% to $2.83 after the company announced a strategic partnership with Haveli Investments, including a $150 million investment.</li>
<li>LendingTree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) rose 24.2% to $46.39 after the company beat first-quarter estimates and issued strong guidance.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) climbed 19.2% to $11.19 following a first-quarter revenue beat.</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) rose 15.5% to $59.94 following upbeat quarterly results.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) rose 15.2% to $46.88 following better-than-expected earnings.</li>
<li>LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) climbed 13.4% to $9.32 following strong quarterly earnings.</li>
<li>E2open Parent Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) gained 12.5% to $4.7950 following upbeat results.</li>
<li>Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) shares gained 12.1% to $40.04 as the company reported stronger-than-expected results for its first quarter on Monday. The company said Jeff Cote will retire as CEO and President. Sensata said it sees second-quarter adjusted earnings of 89 cents to 95 cents per share on revenue of $1.025 billion to $1.055 billion.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) gained 9.2% to $108.28 after the company reported better-than-expected first quarter earnings and issued strong guidance.</li>
<li>Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) surged 8.4% to $163.77 after the company reported better-than-expected second-quarter financial results.</li>
<li>Trane Technologies plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TT#NYSE">TT</a>) gained 8.2% to $325.43  after the company reported a first-quarter earnings beat and raised its FY24 guidance.</li>
<li>Brinker International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) climbed 7.5% to $53.38 after the company reported strong third-quarter financial results and raised FY24 guidance.</li>
<li>The Timken Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKR#NYSE">TKR</a>) rose 7.2% to $92.96 following upbeat earnings.</li>
<li>Corning Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) climbed 7% to $33.99 following better-than-expected quarterly earnings.</li>
<li>Commvault Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) climbed 6.4% to $105.87 following strong earnings.</li>
<li>Zebra Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) gained 6% to $318.05 after the company reported better-than-expected first-quarter results, and updated FY24 guidance.</li>
<li>ACI Worldwide, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIW#NASDAQ">ACIW</a>) gained 5.7% to $34.99 after the company reported better-than-expected first-quarter results.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) shares rose 5.5% to $97.25 following a first-quarter earnings beat.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) gained 5.1% to $33.07 after the company reported better-than-expected quarterly financial results.</li>
<li>NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) rose 4.5% to $258.20 after the company reported better-than-expected quarterly financial results and issued guidance.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/04/38316287/netflix-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Netflix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>

On Tuesday,&nbsp;Tenet Healthcare Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>)&nbsp;reported first-quarter sales of $5.37 billion, up around 7% year over year, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $5.15 billion</a>. Tenet Healthcare operates hospitals and healthcare facilities.
&#8220;We have had an outstanding start to the year highlighted by strong growth in revenues, admissions, and profitability,&#8221; said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet.&nbsp;
Adjusted EBITDA&nbsp;in first-quarter 2024 was $1.024 billion compared to $832 million a year ago, reflecting&nbsp;strong same-hospital&nbsp;admission growth, favorable payer mix, and improved contract labor costs, partially offset by&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/b38513861/tenet-reports-first-quarter-2024-results-well-in-excess-of-guidance-raises-2024-financial-outlook" rel="noreferrer noopener">higher medical fees</a>.&nbsp;
Ambulatory Care net operating revenues increased 9.9% to $995 million, driven by&nbsp;strong&nbsp;net revenue per case growth, acquisitions and opening of de novo facilities, and increased service lines.
Surgical business same-facility system-wide net patient service revenues increased 6.4%, with cases down 0.4% and net&nbsp;revenue&nbsp;per case up 6.8%.&nbsp;
Hospital Operations and Services revenues increased 6.2% to $4.4 billion, primarily due to increased admissions, favorable payer mix, and improved pricing yield. This was partially offset by the impact of hospital sales in the first quarter of 2024.
Outlook: Tenet Healthcare raised its fiscal year 2024 revenues guidance to $20 billion—$20.4 billion, up from prior guidance of $19.9 billion—$20.3 billion and the consensus of $20.37 billion.
The guidance includes Hospital segment sales of $$15.85 billion-$16.1 billion and Ambulatory Segment sales guidance of $4.15 billion-$4.3 billion.
The company forecasts adjusted EPS of $8.37-$9.41 versus a consensus of $6.11.
The fiscal year 2024 adjusted EBITDA outlook&nbsp;is expected&nbsp;to be $3.5 billion to $3.7 billion, a $215 million increase.
Tenet Healthcare expects second-quarter revenue of $4.9 billion—$5.1 billion, versus the consensus of $4.98 billion. It sees adjusted EPS of $1.58-$1.98&nbsp;, versus the consensus of $1.41.
Price Action:&nbsp;THC shares are up 9.97% at $109.08&nbsp;at&nbsp;the last check Tuesday.

<h3>Gainers</h3>
<ul>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock moved upwards by 50.0% to $2.04 during Tuesday's pre-market session. The company's market cap stands at $2.6 million. </li>
<li>GeneDx Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) shares rose 43.54% to $15.79. The company's market cap stands at $411.3 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>BioRestorative Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRTX#NASDAQ">BRTX</a>) shares moved upwards by 16.93% to $1.45. The company's market cap stands at $9.8 million. </li>
<li>Vaccinex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCNX#NASDAQ">VCNX</a>) shares moved upwards by 15.72% to $6.77. The company's market cap stands at $10.7 million. </li>
<li>Addex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) stock moved upwards by 14.19% to $8.61. The market value of their outstanding shares is at $9.2 million. </li>
<li>Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) stock increased by 9.93% to $109.0. The company's market cap stands at $10.8 billion. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>SHL Telemedicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLT#NASDAQ">SHLT</a>) stock decreased by 10.0% to $5.0 during Tuesday's pre-market session. The company's market cap stands at $81.9 million. </li>
<li>Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) stock declined by 8.87% to $1.33. The market value of their outstanding shares is at $244.3 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares fell 8.17% to $0.51. The market value of their outstanding shares is at $13.7 million. </li>
<li>GE HealthCare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) shares declined by 7.81% to $82.0. The market value of their outstanding shares is at $37.4 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Virios Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRI#NASDAQ">VIRI</a>) stock fell 7.28% to $0.44. The market value of their outstanding shares is at $8.3 million. </li>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) shares decreased by 7.15% to $1.82. The market value of their outstanding shares is at $1.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATNF

BRTX

GCTK

NKTR

SHLT

VCNX

VIRI

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Tenet Healthcare shares are trading higher after the company reported better-than-expected Q1 earnings and issued strong guidance.

U.S. stocks appear&nbsp;to be&nbsp;on the back foot early on Tuesday, with index futures trading modestly lower in early pre-market activity. Caution&nbsp;reigns supreme as traders anxiously await the Federal Reserve&#8217;s&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38508875/another-rate-hike-coming-in-2024-macquarie-economists-reverse-forecast-warn-of-incr" rel="noreferrer noopener">interest rate decision</a>&nbsp;on Wednesday.&nbsp;A&nbsp;hawkish stance, either&nbsp;in the post-meeting policy statement or Fed Chair Jerome Powell&#8217;s remarks,&nbsp;could trigger a market pullback.&nbsp;&nbsp;However, recent scorching inflation data has already tempered market expectations for rate cuts.
Adding to the market&#8217;s volatility, the busy earnings season commences this week. Company&nbsp;results and their outlooks for the future could significantly impact stock prices.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.16%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.15%</td>
</tr>
<tr>
<td>Dow</td>
<td>-0.08%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.51%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption"> In <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noreferrer noopener">premarket</a>&nbsp;trading on Tuesday, the&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) climbed 0.20% to $509.27,&nbsp;and the&nbsp;Invesco QQQ ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.29% to $432.27, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.</figcaption></figure>
Cues From The Last Session:
Stocks closed Monday&#8217;s session on a positive note, although trading was marked by some degree of volatility. The major indices opened the session higher, as the positive momentum from Friday carried over into the new week, with Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) leading from the front. They stayed above the unchanged line for the better part of the morning before reversing course in late afternoon trading.
While apprehension ahead of the week&#8217;s key earnings and data was attributed to the weakness, the stock recovered thereafter to close higher for a second straight session. Market participants also blamed the intraday slide on an increase in the U.S. Treasury&#8217;s June quarter borrowing estimates.
The gains were led by consumer discretionary stocks, while communication services stocks dragged.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+0.35%</td>
<td>15,983.08</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>+0.32%</td>
<td>5,116.17</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>+0.38%</td>
<td>38,386.09</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>+0.70%</td>
<td>2,016.03</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Ahead of the Fed meeting, Wharton Professor Jeremy Siegel, Senior Economist to&nbsp;WisdomTree, said in his weekly commentary, that the market is currently pricing in only slim chances of rate cuts this year. On Wednesday, the economist expects Powell to repeat the rhetoric that the central bank doesn&#8217;t have enough confidence to lower rates.
Siegel expects the press to probe as to whether the Fed was contemplating rate hikes. &#8220;Powell's answer to that may be illuminating,&#8221; he said. &#8220;It is quite possible with two more inflation prints before the June meeting, that the Fed can get enough information to signal imminent cuts. I'm not ruling out a rate cut at the June meeting.&#8221;
Fundstrat expressed confidence in the market recovery taking root. &#8220;Stocks survive &#8216;fragility test&#8217; of April. Roadmap for May more constructive = recovery towards S&amp;P 5,200,&#8221; said the firm in a post on X.
Upcoming Economic Data:
<ul>
<li>A two-day Federal Open Market Committee meeting gets underway on Tuesday, with the decision due only on Wednesday.</li>
<li>The Labor Department is scheduled to release its employment cost index for the first quarter at 8:30 a.m. EDT. Economists, on average, expect the index to climb 1% quarter-over-quarter, faster than the 0.9% increase in the fourth quarter.</li>
<li>The S&amp;P Case-Shiller and Federal House Finance Agency are due to release the results of their respective house price surveys at 9 a.m. EDT.</li>
<li>ISM-Chicago will release the results of its regional manufacturing survey at 9:45 a.m. EDT. The Chicago business barometer index is expected to rise from 41.4 in March to 45 in April. A reading below 50 shows contraction. </li>
<li>The Conference Board&#8217;s consumer confidence index, due at 10 a.m. EDT, may have eased slightly from 104.7 in March to 103.5 in April.</li>
</ul>
See also: <a href="https://www.benzinga.com/money/best-futures-trading-software">Best Futures Trading Software</a>
Stocks In Focus: 
<ul>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) fell over 9.5% <a href="https://www.benzinga.com/premarket">in premarket trading</a> following its earnings announcement.</li>
<li>Other stocks moving on earnings are Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) (down about 4%), MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) (down about 5.4%), Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) (up about 16%), Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) (down over 4%) and Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) (down over 5%).</li>
<li>Tesla slipped over 1% following its 15%+ jump on Monday.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), Archer-Daniels-Midland Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>), The Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>), McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>), PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) and Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) are among the <a href="https://www.benzinga.com/calendars/earnings">notable companies reporting earnings ahead of the market open.</a></li>
<li>Notable names reporting after the close are Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), ONEOK, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>), Pinterest, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>), Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>), Unum Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNM#NYSE">UNM</a>). Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), Stryker Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>), RenaissanceRe Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>), Prudential Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>), Diamondback Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>), The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) and Chesapeake Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHK#NASDAQ">CHK</a>).</li>
</ul>
Commodities, Bonds, and Global Equity Markets:
Crude oil futures rose modestly on Tuesday and yet traded at the sub-$83-a-barrel mark and gold futures moved sideways around the $2,300 level.
The 10-year note yield held around the 4.628% mark.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) has pulled back over the past 24 hours and traded under $62,000.
Asian stocks moved about in a lackluster manner before closing on a mixed note. While the Japanese market, which reopened after a public holiday, rallied strongly, Chinese equities pulled back as investors weighed in the private-sector activity data.
The Japanese yen weakened after Monday&#8217;s surge achieved on the back of government intervention to prop up the currency. 
European markets were lower in early trading as investors digested a slew of domestic economic data. The euro area expanded more than expected in the first quarter, as the economy emerged out of a recession, and the March inflation came in line with forecasts. 
Read Next: <a href="https://www.benzinga.com/news/earnings/24/04/38481553/will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports">Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week</a>
illustration created using artificial intelligence via MidJourney.

Equities

Futures

Previews

Economics

Federal Reserve

Pre-Market Outlook

$BTC

AMZN

FANG

LSCC

PINS

PYPL

SBUX

SMCI

SWKS

TSLA

Wall Street On Edge Ahead Of Fed Decision, Spotlight Falls On Amazon And AMD Earnings: Analyst Says Stocks Survive 'Fragility Test' As April Ends

2024 Outlook1
Tenet&#39;s Outlook for full year 2024 (consolidated and by segment) and second quarter 2024 follows. This outlook reflects the completion of the sale of three Coastal South Carolina hospitals on January 31, 2024 and the completion of the sale of six California hospitals on March 31, 2024.
<table cellspacing="0">
<tbody>
<tr>
<td colspan="1" rowspan="1">
CONSOLIDATED ($ in millions, except per share amounts)
</td>
<td colspan="1" rowspan="1">
FY 2024 Outlook
</td>
<td colspan="1" rowspan="1">
Second Quarter 
			2024 Outlook
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Net operating revenues
</td>
<td colspan="1" rowspan="1">
$20,000 to $20,400
</td>
<td colspan="1" rowspan="1">
$4,900 to $5,100
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Net income from continuing operations available to Tenet common stockholders
</td>
<td colspan="1" rowspan="1">
$2,622 to $2,762
</td>
<td colspan="1" rowspan="1">
$150 to $195
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted EBITDA
</td>
<td colspan="1" rowspan="1">
$3,500 to $3,700
</td>
<td colspan="1" rowspan="1">
$835 to $885
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted EBITDA margin
</td>
<td colspan="1" rowspan="1">
17.5% to 18.1%
</td>
<td colspan="1" rowspan="1">
17.0% to 17.4%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Diluted income per common share from continuing operations
</td>
<td colspan="1" rowspan="1">
$25.96 to $27.35
</td>
<td colspan="1" rowspan="1">
$1.49 to $1.93
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted net income from continuing operations
</td>
<td colspan="1" rowspan="1">
$845 to $950
</td>
<td colspan="1" rowspan="1">
$160 to $200
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted diluted earnings per share from continuing operations
</td>
<td colspan="1" rowspan="1">
$8.37 to $9.41
</td>
<td colspan="1" rowspan="1">
$1.58 to $1.98
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Equity in earnings of unconsolidated affiliates
</td>
<td colspan="1" rowspan="1">
$220 to $230
</td>
<td colspan="1" rowspan="1">
$50 to $60
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Depreciation and amortization
</td>
<td colspan="1" rowspan="1">
$830 to $860
</td>
<td colspan="1" rowspan="1">
$210 to $220
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Interest expense
</td>
<td colspan="1" rowspan="1">
$825 to $835
</td>
<td colspan="1" rowspan="1">
$220 to $230
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Income tax expense5
</td>
<td colspan="1" rowspan="1">
$945 to $995
</td>
<td colspan="1" rowspan="1">
$80 to $95
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Net income available to NCI
</td>
<td colspan="1" rowspan="1">
$750 to $800
</td>
<td colspan="1" rowspan="1">
$160 to $170
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Weighted average diluted common shares
</td>
<td colspan="1" rowspan="1">
~101 million
</td>
<td colspan="1" rowspan="1">
~101 million
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
NCI cash distributions
</td>
<td colspan="1" rowspan="1">
$665 to $715
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Net cash provided by operating activities6
</td>
<td colspan="1" rowspan="1">
$1,725 to $2,075
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted net cash provided by operating activities6
</td>
<td colspan="1" rowspan="1">
$1,825 to $2,125
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Capital expenditures
</td>
<td colspan="1" rowspan="1">
$775 to $875
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Free cash flow &ndash; continuing operations6
</td>
<td colspan="1" rowspan="1">
$950 to $1,200
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted free cash flow &ndash; continuing operations6
</td>
<td colspan="1" rowspan="1">
$1,050 to $1,250
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
</tbody>
</table>

Tenet Healthcare Raises FY24 Outlook: Revenue $20B-$20.40B (Up From $19.90B-$20.30B) Vs. $20.37B Estimate, Adj. EPS  $8.37-$9.41 Vs. $6.11 Estimate

Tenet Healthcare Q2 Outlook: Revenue $4.9B-$5.1B Vs. $4.98B Estimate, Adj. EPS $1.58-$1.98 Vs. $1.41 Estimate, GAAP EPS $1.49-$1.93 Vs. $1.38 Estimate

Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) reported quarterly earnings of $3.22 per share which beat the analyst consensus estimate of $1.43 by 125.17 percent. This is a 126.76 percent increase over earnings of $1.42 per share from the same period last year. The company reported quarterly sales of $5.368 billion which beat the analyst consensus estimate of $5.152 billion by 4.18 percent. This is a 6.91 percent increase over sales of $5.021 billion the same period last year.

Earnings Beats

Tenet Healthcare Q1 2024 Adj EPS $3.22 Beats $1.43 Estimate, Sales $5.368B Beat $5.152B Estimate

Corporate <a href="https://www.benzinga.com/markets/equities/24/04/38471231/strong-quarterly-earnings-fuel-market-optimism-despite-inflation-concerns-slowing-economic-growt">earnings came to the market&#8217;s rescue in the past week,</a> helping to overcome rate fears. As we look ahead to the unfolding week, it remains to be seen whether the tech earnings deluge can keep the rally&#8217;s momentum going. 
The Week That Was: High-profile Magnificent Seven earnings panned out mostly positively for the market, with Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) the outlier. The social media giant&#8217;s stock fell sharply as traders fretted over the soft second-quarter revenue guidance and the company&#8217;s massive AI investment plans. 
Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) managed to appease the Street despite the double miss as it held out the promise of an expeditious launch of a more affordable EV. 
With the earnings season now halfway through, the percentage of S&amp;P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages, <a href="https://insight.factset.com/sp-500-earnings-season-update-april-26-2024?utm_source=Direct&amp;utm_medium=Email&amp;utm_campaign=FO-04-26-2024&amp;utm_content=httpsinsightfactsetcomsp500earningsseasonupdateapril262024">said </a>FactSet in a report.
The blended first-quarter earnings growth of S&amp;P 500 companies is estimated at 3.5%, up from the 0.6% growth estimated in the week ended April 19, the financial data analytics firm said. If the trend holds, the S&amp;P 500 companies are on track to report earnings growth for the third straight quarter.
Of the 11 S&amp;P sector classes, eight sectors reported year-over-year earnings growth, led by communication services, utilities, IT, and consumer discretionary sectors. On the other hand, healthcare, energy, and materials have reported year-over-year earnings declines.
See Also: <a href="https://www.benzinga.com/money/best-tech-stocks">Best Tech Stocks Right Now</a>
Look Ahead: The unfolding week will see 175 S&amp;P 500 companies and 6 Dow 30 components releasing their quarterly scorecards. The earnings roster includes two Magnificent Seven companies, namely Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Amazon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), e-commerce retailers, payment processors, restaurants, and energy and REIT companies.
Earnings from Apple and Amazon could be market-moving, given the weighting of these stocks in the S&amp;P 500 Index. Also, Apple is considered a bellwether, given its exposure to consumers. Morgan Stanley&#8217;s Erik Woodring expects Apple to report a slightly beat but guide June quarter revenue down. 
Investors are likely to keep a close eye on performance in China, Apple&#8217;s updated capital return framework, and capital expenditures, the analyst said.
That said, the analyst is positive on the stock ahead of its annual Worldwide Developers&#8217; Conference due on June 10th. &#8220;With Apple&#8217;s biggest WWDC event on June 10th, we&#8217;d buy post-earnings weakness,&#8221; he said.
Amazon will likely continue to report double-digit sales and profit growth in the first quarter, according to Telsey Advisory Group analyst Joseph Feldman. The analyst premised his optimism on the strength of online spending, gains from expanded merchandise and faster fulfillment, and stabilization (and growth) of AWS. 
&#8220;Importantly, we expect [a] greater focus on profits supported by the growth of higher margin categories and services, such as advertising, media, and AWS (partly helped by AI-related upgrades), the redesigned distribution network&#8230;.. and cost savings,&#8221; he said.
Notable among the <a href="https://www.benzinga.com/calendars/earnings">companies reporting earnings this week</a> are:
Monday 
<ul>
<li>Before the bell: JinkoSolar Holding Co., Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>), ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>), Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>), SoFi Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>)</li>
<li>After the close: F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>), Everest Group, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>), NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>), Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>), MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>), Qiagen N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QGEN#NYSE">QGEN</a>), Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>), Sanmina Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>), Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)</li>
</ul>
Tuesday 
<ul>
<li>Before the bell: 3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), Archer-Daniels-Midland Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>), The Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>), McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>), PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>)</li>
<li>After the close: Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), ONEOK, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>), Pinterest, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>), Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>), Unum Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNM#NYSE">UNM</a>). Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), Stryker Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>), RenaissanceRe Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>), Prudential Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>), Diamondback Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>), The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>), Chesapeake Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHK#NASDAQ">CHK</a>)</li>
</ul>

Wednesday 
<ul>
<li>Before the bell: Bausch + Lomb Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>), CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), DuPont de Nemours, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>), The Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>), Garmin Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NYSE">GRMN</a>), GSK plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>), The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>), KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), Logitech International S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>), Mastercard Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>), Pfizer, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), Wingstop Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>), Yum! Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>)</li>
<li>After the close: Albemarle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>), The Allstate Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>), Beazer Homes USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>), C.H. Robinson Worldwide, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>), Devon Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>), eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>), Etsy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>), First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), Freshworks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>), Kulicke and Soffa Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLIC#NASDAQ">KLIC</a>), Marathon Oil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRO#NYSE">MRO</a>), MetLife, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>), MGM Resorts International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>), NETGEAR, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTGR#NASDAQ">NTGR</a>), Qorvo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>), Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>), Upwork Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>), Wolfspeed, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>), Zillow Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>)</li>
</ul>
Thursday 
<ul>
<li>Before the bell: ArcelorMittal S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MT#NYSE">MT</a>), ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>), CyberArk Software Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>), Ferrari N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RACE#NYSE">RACE</a>), Intercontinental Exchange, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>), Kimco Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIM#NYSE">KIM</a>), Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>), PENN Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>), Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>), Zoetis Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTS#NYSE">ZTS</a>)</li>
<li>After the close: Amgen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>), BJ&#8217;s Restaurants, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJRI#NASDAQ">BJRI</a>), Booking Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>), Cloudflare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>), Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), Consolidated Edison, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>), DraftKings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>), Five9, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>), Expedia Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>), Illumina, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>), Live Nation Entertainment, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>), United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>), Regency Centers Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REG#NASDAQ">REG</a>), Reinsurance Group of America, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>), Pioneer Natural Resources Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PXD#NYSE">PXD</a>), Opendoor Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>), Monster Beverage Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>)</li>
</ul>
Friday 
<ul>
<li>Before the bell: American Axle &amp; Manufacturing Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>), Cboe Global Markets, Inc. (CBOE: CBOE), Fluor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>), The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>), Owens &amp; Minor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>), XPO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>)</li>
</ul>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), an exchange-traded fund that tracks the performance of the broader S&amp;P 500 Index, ended Friday&#8217;s session up 0.95% at $508.26, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data. </a>The ETF has pulled back from its all-time high (intraday) of $524.61 hit on March 28. The Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), an ETF levered more to high-profile, non-financial tech stocks, rose 1.54% to $431.
Read Next: <a href="https://www.benzinga.com/news/earnings/earnings-misses/24/04/38464570/us-energy-stocks-fall-following-oil-giants-subdued-earnings-reports">US Energy Stocks Fall Following Oil Giants&#8217; Subdued Earnings Reports</a>

AAPL

ABBV

AMGN

BBAI

BIIB

BJRI

BKNG

BLCO

CBOE

CHRW

CHTR

CMCSA

COIN

CYBR

DKNG

EBAY

ETSY

EXPE

FIVN

FRSH

FSLR

GILD

GRMN

ILMN

INTC

JBLU

JNPR

KLAC

KLIC

LOGI

LRCX

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week

Deep-pocketed investors have adopted a bearish approach towards Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in THC usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for Tenet Healthcare. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 58% bearish. Among these notable options, 2 are puts, totaling $133,288, and 10 are calls, amounting to $579,946.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $92.5 to $97.5 for Tenet Healthcare over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Tenet Healthcare's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tenet Healthcare's whale trades within a strike price range from $92.5 to $97.5 in the last 30 days. 
<h3>Tenet Healthcare 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714149959_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$6.0</td>
<td>$5.8</td>
<td>$6.0</td>
<td>$92.50</td>
<td>$139.2K</td>
<td>49</td>
<td style="text-align: right;">784</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$3.5</td>
<td>$3.3</td>
<td>$3.3</td>
<td>$92.50</td>
<td>$98.6K</td>
<td>1.0K</td>
<td style="text-align: right;">102</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$5.0</td>
<td>$4.9</td>
<td>$5.0</td>
<td>$92.50</td>
<td>$90.7K</td>
<td>49</td>
<td style="text-align: right;">201</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$6.2</td>
<td>$6.0</td>
<td>$6.0</td>
<td>$92.50</td>
<td>$72.6K</td>
<td>49</td>
<td style="text-align: right;">785</td>
</tr>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/17/24</td>
<td>$6.1</td>
<td>$5.9</td>
<td>$5.9</td>
<td>$92.50</td>
<td>$59.0K</td>
<td>49</td>
<td style="text-align: right;">402</td>
</tr>
</tbody>
</table>

<h3>About Tenet Healthcare</h3>
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Following our analysis of the options activities associated with Tenet Healthcare, we pivot to a closer look at the company's own performance.
<h3>Where Is Tenet Healthcare Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 681,347, the THC's price is down by -1.89%, now at $95.67. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 4 days.</li>
</ul>
<h3>What The Experts Say On Tenet Healthcare</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $115.0.
<ul>
<li>An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $104. </li>
<li>Maintaining their stance, an analyst from Deutsche Bank continues to hold a Buy rating for Tenet Healthcare, targeting a price of $126. </li>
<li>An analyst from Wells Fargo has decided to maintain their Overweight rating on Tenet Healthcare, which currently sits at a price target of $115. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Tenet Healthcare options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Check Out What Whales Are Doing With THC

Whales with a lot of money to spend have taken a noticeably bearish stance on Tenet Healthcare.
Looking at options history for Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 27% of the investors opened trades with bullish expectations and 72% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $665,976 and 2, calls, for a total amount of $219,317.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $90.0 and $105.0 for Tenet Healthcare, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Tenet Healthcare's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tenet Healthcare's whale activity within a strike price range from $90.0 to $105.0 in the last 30 days. 
<h3>Tenet Healthcare Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713450735_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>THC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$3.3</td>
<td>$3.2</td>
<td>$3.2</td>
<td>$95.00</td>
<td>$166.4K</td>
<td style="text-align: right;">664</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/21/24</td>
<td>$14.9</td>
<td>$14.4</td>
<td>$14.4</td>
<td>$105.00</td>
<td>$144.0K</td>
<td style="text-align: right;">209</td>
<td style="text-align: right;">100</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$14.2</td>
<td>$14.2</td>
<td>$14.2</td>
<td>$105.00</td>
<td>$142.0K</td>
<td style="text-align: right;">209</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$9.8</td>
<td>$9.4</td>
<td>$9.5</td>
<td>$97.50</td>
<td>$105.4K</td>
<td style="text-align: right;">103</td>
<td style="text-align: right;">54</td>
</tr>
<tr>
<td>THC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$14.5</td>
<td>$13.8</td>
<td>$14.5</td>
<td>$105.00</td>
<td>$72.5K</td>
<td style="text-align: right;">209</td>
<td style="text-align: right;">200</td>
</tr>
</tbody>
</table>

<h3>About Tenet Healthcare</h3>
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of December 2023) and over 450 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
<h3>Where Is Tenet Healthcare Standing Right Now?</h3>
<ul>
<li>With a volume of 632,812, the price of THC is down -4.28% at $91.89. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 12 days.</li>
</ul>
<h3>Expert Opinions on Tenet Healthcare</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $116.75.
<ul>
<li>An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $104. </li>
<li>An analyst from Wells Fargo has decided to maintain their Overweight rating on Tenet Healthcare, which currently sits at a price target of $115. </li>
<li>An analyst from Deutsche Bank has decided to maintain their Buy rating on Tenet Healthcare, which currently sits at a price target of $126. </li>
<li>An analyst from Wolfe Research upgraded its action to Outperform with a price target of $122. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Tenet Healthcare, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Tenet Healthcare

Tenet Healthcare surges 11% on quarterly beats, 2024 guidance raise

Tenet Healthcare Corporation (THC) Q1 2024 Earnings Call Transcript

Tenet Healthcare Corporation 2024 Q1 - Results - Earnings Call Presentation

In a report released today, Ben Hendrix from RBC Capital maintained a Buy rating on Tenet Healthcare (THC – Research Report), with a price target o...

RBC Capital Remains a Buy on Tenet Healthcare (THC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merit Medical Systems (MMSI – Research Report), Inari Medical (NA...

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Andlauer Healthcare Group (ANDHF – Research Report) ...

Analysts Offer Insights on Healthcare Companies: Andlauer Healthcare Group (OtherANDHF) and Tenet Healthcare (THC)

Tenet Healthcare M&A transactions are building an empire - Steamboat Capital Partners 1Q letter

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Tenet Healthcare (THC – Research Report). The associated price target was...

Tenet Healthcare's Strong Q1 Performance and Upward Guidance Justify Buy Rating

Barclays analyst Andrew Mok CFA maintained a Buy rating on Tenet Healthcare (THC – Research Report) today and set a price target of $147.00. The co...

Barclays Reaffirms Their Buy Rating on Tenet Healthcare (THC)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BridgeBio Pharma (BBIO – Research Report), GE Health...

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), GE Healthcare Technologies Inc (GEHC) and Tenet Healthcare (THC)

ANDHF

BBIO

MMSI

NARI

Press Releases

UCI Health Reaches Definitive Agreement to Acquire Four Southern California Hospitals From Tenet Healthcare Corporation

Tenet Reports Fourth Quarter and FY 2023 Results; Provides 2024 Financial Outlook

Tenet Calls for Full Redemption of 4.875% Senior Secured First Lien Notes due 2026

Tenet to Participate in Barclays 26th Annual Global Healthcare Conference

Tenet to Sell Two Hospitals and Enter into a Revenue Cycle Services Partnership with Adventist Health

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tenet Healthcare Stock (NYSE:THC), Short Interest Report

People Also Watch